PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT



Similar documents
Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Case of the. Month October, 2012

Today s Topics. Tumors of the Peritoneum in Women

Practical Effusion Cytology

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Effusions: Mesothelioma and Metastatic Cancers

Diagnostic Challenge. Department of Pathology,

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

The develpemental origin of mesothelium

Immunohistochemical differentiation of metastatic tumours

Ovarian tumors Ancillary methods

Case presentation. Awatif Al-Nafussi

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Diagnosis of Mesothelioma Pitfalls and Practical Information

Update on Mesothelioma

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Académie internationale de Pathologie - Division arabe XX ème congrès novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Case presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Pathology of the Female Peritoneum, Common and Uncommon Problems

National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)

How To Diagnose And Treat A Tumour In An Effusion

Something Old, Something New.

Notice of Faculty Disclosure

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin

Cytopathology Case Presentation #8

Surgical Staging of Endometrial Cancer

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32

Frequently Asked Questions About Ovarian Cancer

A 70-year old Man with Pleural Effusion

Cystic mesothelioma of the peritoneum

3-F. Pathology of Mesothelioma

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

Carcinosarcoma of the Ovary

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

PROTOCOL OF THE RITA DATA QUALITY STUDY

microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS

The menstrual cycle Hypophysis

The Diagnosis of Cancer in the Pathology Laboratory

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

How To Treat A Uterine Sarcoma

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

The Adnexal Mass and Early Ovarian Cancer

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses

Rare Thoracic Tumours

How To Test For Cancer

Male. Female. Death rates from lung cancer in USA

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis

Immunostain Update: Diagnosis of Metastatic Breast Carcinoma, Emphasizing the Distinction from Gynecologic Cancers

Diagnosis and treatment of benign multicystic peritoneal mesothelioma

Tubulocystic Carcinoma of the Kidney, a Rare Distinct Entity

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

Atypical uterine leiomyoma: a case report and review of the literature

Ovarian Cancer 101 Jessica McAlpine, MD

Anatomic Pathology / PERITONEAL MESOTHELIOMA AND SEROUS CARCINOMA

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, HT, see Serotonin

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

Common Cancers & Hereditary Syndromes

Renal Pathology Update. Sundus Hussein MD, FRCPC

INFLAMMATORY PLEURAL EFFUSION

Histopathology of Major Salivary Gland Neoplasms

A succesfull case of HIPEC in a peritoneal mesothelioma patient

Corporate Medical Policy

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

ProSono Copyright Ovarian Pathology

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis

Fallopian Tube Cancer

MESOTHELIAL LESIONS OF THE PERITONEUM

Endometrial Cancer Treatment

YOUR LUNG CANCER PATHOLOGY REPORT

Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S.

Case Report A Case of Unsuspected Peritoneal Mesothelioma Occurring with Colonic Adenocarcinoma Masquerading as Peritoneal Metastases

Case based applications part III

Luis D. Carcorze Soto, MD PGY-3

Transcription:

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia Università Cattolica Roma (*) Relatore Facebook

The papillary serous carcinoma of the peritoneum is a rare malignant epithelial tumor histologically indistinguishable from high-grade papillary serous carcinoma of the ovary. The distinction between both of these is sometimes difficult, especially in cases of advanced metastatic disease.

In this study, we report the case of a woman 57 years old, previously operated by bilateral hysteroannessiectomy because of uterine fibromatosis, with a clinical history characterized by abdominal ache associated with fever, weight loss and ascites. The laparoscopic exploration of the peritoneal cavity, revealed the presence of diffuse and multiple nodular structures with papillary aspects, involving the omentum, the ascending and transverse colon, and cecum.

The histological evaluation showed a high-grade papillary serous carcinoma, exhibits sheets of cells with marked nuclear atypia, isolated bizarre cells, high mitotic activity and foci of necrosis. The immuno-histochemical profile showed a diffuse and strong positivity to p53, WT-1, CK7 and CK18, a moderate nuclear positivity to Estrogen receptors and a negativity to CK20, Calretinin and Progesterone receptors.

The first histological diagnosis was peritoneal carcinomatosis incidental to papillary serous carcinoma of high-grade ovarian cancer. However, the revision of the uterus and the uterine annexes ruled out the presence of invasive or in situ carcinomatous sores in bilateral ovarian site.

The differential diagnosis of high-grade primary peritoneal serous papillary carcinoma (PPSPC) includes metastatic (primary) ovarian serous papillary carcinoma (POSPC), endometrial serous carcinoma, malignant mesothelioma, metastatic adenocarcinoma of the breast, and metastatic papillary thyroid carcinoma arising within struma ovarii.

Type of neoplasm POSPC Endometrial serous carcinoma Malignant mesothelioma Metastatic carcinoma from breast Metastatic papillary thyroid carcinoma Morphologic and immunohis. features Diffuse parenchima involvement of ovaries; WT- 1+ and p53+ Uterine endometrial involvement; weak or absent staining with WT-1 Cells are cuboidal to rounded with eosinophilic cytoplasm; positive mesothelial markers, including calretinin and CK5/6. Clinical history of the primary breast carcinoma; BRST-2 + (*) and mammaglobin+ Nuclear inclusion and grooves may be seen; Thyroglobin + and TTF-1+ (*) Gross Cystic Disease Fluid Protein-15 (GCDFP-15)

Criteria for the separation of POSPC from PPSPC have been establisched by the Gynecologic Oncology Group: the neoplasm is classified as a primary peritoneal serous carcinoma if the majority of the tumour is situaded in the peritoneum with unremarkable ovaries, or if only ovarian surface or minimal ovarian stromal invasion is present.

These clinical and instrumental data associated with the Gynecologic Oncology Group criteria relating to the differential diagnosis, allowed to carry out the diagnosis of primary peritoneal papillary serous carcinoma.

In conclusion, a careful clinical, anamnestic, histological and immuno-histochemical evaluation is essential to express a correct diagnosis and to plan a suitable treatment. The primary peritoneal papillary serous carcinoma requires a close follow-up because of poor prognosis that is comparable or worse than the papillary serous ovarian carcinoma.

References: 1) Vang R., Shih IeM, Kurman R.J. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv. Anat. Pathol 2009; 16:267-82. 2) Kurman R.J., Shih IeM, The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J Surg Pathol 2010; 34:433-43. 3) Gross AL, Kurman RJ, Vang R, et al. Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics. J Oncol 2010; 2010:126965. 4) Liu Q, Lin JX, Shi QL, et al. Primary peritoneal serous papillary carcinoma: a clinical and pathological study. Pathol Oncol Res 2011; 17:713-9. 5) Shelly Sehgal, Reena Agarwal, et al. Primary serous carcinoma of peritoneum: a case report ; IJCRI 2012; vol 3, N.10; 6) Gilani S., Tashjian R., Fathallah L., High-grade primary peritoneal serous papillary carcinoma with a wide differential diagnosis: a diagnostic challenge ; Pathologica 2012; 104:442-445.